Process patent-related disputes seen intensifying

Published: 2004-03-30 06:59:00

Updated: 2004-03-30 06:59:00

With Korean pharmaceutical firms vigorously aiming to launch the first generic versions of major original drugs whose patent is to be soon expired, a number of patent disputes among domestic pharmaceutical firms and foreign counterparts would likely be intensifying, market sources said recently.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK